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Abstract 
Research on adipobiology has recog-
nized the browning process of white
adipocytes as a potential therapeutic strate-
gy for the treatment of obesity and related
morbidities. Physical exercise stimulates
the secretion of myokines, such as b-
aminoisobutyric acid (BAIBA), which in
turn promotes adaptive thermogenesis.
White adipocyte conversion to brown cells
involves dynamic changes in lipid droplet
(LD) dimension and in the transcription of
brown-specific marker genes. This study
analyzes the effect of different doses of
BAIBA and at different days of develop-
ment on 3T3-L1 cells by evaluating mor-
phological changes in LDs and the expres-
sion of browning gene markers. Results
suggested that the highest concentration of
BAIBA after 4 days of differentiation pro-
duced the most significant effects. The
number of LDs per cell increased in com-
parison to control cells, whereas the surface
area significantly decreased. Brown
adipocyte markers were up-regulated, but
the effect of treatment was lost at 10 days of
differentiation.
The thermogenic program induced by
BAIBA may reflect a rapid adaptation of
adipose tissue to physical exercise. This
connection stresses the beneficial impact of
physical exercise on metabolic health.
Introduction 
Regular exercise has been shown to
have many health benefits, both physically
and mentally. Indeed, it increases metabolic
rate, helping in weight loss, improves
whole-body glucose homeostasis and
increases insulin sensitivity. Recently,
endocrine factors called myokines, pro-
duced by skeletal muscles and released dur-
ing the contraction of muscle fibers, have
been detected and linked to the loss of fat
mass through the activation of thermogene-
sis in adipose tissue.1,2 Thermogenesis is a
physiological process typical of uncoupling
protein 1 (UCP1)-expressing mature brown
adipocytes and recruitable brown-like
adipocytes, the so-called beige or brite
adipocytes.3 In these cells, UCP1 uncouples
the mitochondrial respiration from the pro-
duction of adenosine triphosphate (ATP)
and the energy produced by the catabolic
pathways is released in form of heat.4,5
Brown and beige adipocytes are morpho-
logically distinct from white ones for hav-
ing multiple small lipid droplets (LDs)
instead of a unique fat depot that occupies
the vast majority of the cytoplasm,6 and for
having a high number of mitochondria inti-
mately associated to them.7 It was also
demonstrated that the gene expression pat-
tern of the three cell types is very different;
despite beige adipocytes may be seen as
“intermediate” between white and brown
adipocytes, they present a unique gene
expression pattern with highly specific
molecular markers.8-11
This unique feature of UCP1-express-
ing cells has raised in recent years a great
effort in brown adipobiology and obesity
research, as the induction of browning by
cold exposure, exercise and dietary/phar-
macological factors may represent an effec-
tive way to counteract obesity and its relat-
ed comorbidities.12 In fact, many studies
performed on both in vitro and in vivo mod-
els, which have been recently reviewed,2
showed that the treatment with browning-
inducing factors increases energy expendi-
ture by enhancing the expression of Ucp1
gene and other brown adipose tissue (BAT)
markers. Canonical BAT gene markers
include the elongation of very long chain
fatty acids protein 3 (Elovl3), cell death-
inducing DNA fragmentation factor A
(DFFA)-like effector A (Cidea), PR
domain-containing protein 16 (Prdm16) and
peroxisome proliferator-activating receptor
(PPAR) γ coactivator 1α (Ppargc1a). These
last two genes are deeply involved in mito-
chondrial biogenesis and in early BAT dif-
ferentiation.8
The exercise-induced adaptive thermo-
genesis would not make sense in white adi-
pose tissue (WAT), since exercise per se
increases heat production.13 Therefore,
myokines, such as irisin, myostatin, mete-
orin-like 1 (Metrnl) and b-aminoisobutyric
acid (BAIBA), which are released during
muscle contraction in physical activity, are
claimed as browning-promoting factors in
WAT. 
BAIBA is a non-protein amino acid
originating from the catabolism of thymine
and valine that plays a critical role in
browning and in insulin resistance.14,15
Recently, BAIBA has been shown to protect
osteocytes against reactive oxygen species
and related apoptosis.16 Despite the role of
myokines in WAT browning has been exten-
sively reviewed,2,13 the cellular pathways
through which they exert their action are
mostly unknown. Roberts and colleagues
hypothesized a PPARα-mediated mecha-
nism through which BAIBA positively
affects lipid metabolism in both adipocytes
and hepatocytes.15 However, the exact
molecular pathway of browning, as well as
the remodelling of LDs induced by BAIBA
needs further investigation.
This paper aims to show the effects of
BAIBA treatment on murine 3T3-L1
preadipocytes during their differentiation to
mature adipocytes on morphological and
numerical changes of LDs and on the
expression of a selected gene pattern. The
expression of a core set of brown fat-specif-
ic genes and mitochondrial biogenesis
(Ucp1, Cidea, Elovl3, Ppargc1a, Prdm16
and Cyc1) and a beige marker (Tbx1) was
analyzed. Markers of LD formation and
dynamics such as perilipin 1 (Plin1) and
cell death-inducing DFFA-like effector C
(Cidec) were investigated. Finally, the
expression of brain-derived neurotrophic
factor (Bdnf), a neurotrophin, which has a
role in browning on in vivo models and in
regulating energy balance and insulin sig-
naling,17,18 was also assessed.
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Materials and Methods
Chemicals and culture media
Dulbecco’s modified Eagle medium
(DMEM) enriched with 4.5 g/L D-glucose,
110 mg/L sodium pyruvate and 862 mg/L
L-alanyl-L-glutamine (GlutaMAX™),
DMEM/F-12 (1:1) medium enriched with
GlutaMAX™ and 15 mM 4-(2-hydrox-
yethyl)-1-piperazineethanesulfonic acid
(HEPES), fetal bovine serum (FBS), peni-
cillin/streptomycin solution and ampho-
tericin B solution were purchased from
Gibco by Life Technologies (Thermo Fisher
Scientific Inc., Waltham, MA, USA).
Rosiglitazone was purchased from Cayman
Chemical (Ann Arbor, MI, USA). BAIBA
was purchased in a racemic mixture from
AdipoGen SA (AdipoGen Life Science Inc.,
San Diego, CA, USA). Dipyrromethene
boron difluoride (BODIPY) 493/503 dye,
TRIzol reagent, PureLink™ RNA Mini Kit
and Platinum™ SYBR™ Green qPCR
SuperMix-UDG kit for real time PCR were
purchased from Invitrogen (Thermo Fisher
Scientific Inc.). ImProm-II™ Reverse
Transcription System was purchased from
Promega (Madison, WI, USA). 4,6-
diamidin-2-phenylindole (DAPI)-contain-
ing mounting medium was purchased from
Abcam (Cambridge, MA, USA). All other
chemicals used in the experiment and not
listed above were purchased from Sigma-
Aldrich (Darmstadt, Germany).
Cell culture and treatment
3T3-L1 cells were chosen in the present
study for their extensive use in evaluating
the effects of compounds or nutrients on
adipogenesis and in the potential applica-
tion of various compounds and nutrients in
the treatment of obesity. Moreover, at the
best of our knowledge, the browning effect
of BAIBA on 3T3-L1 cell model was never
investigated. The murine 3T3-L1
preadipocytes (ZenBio Inc., Durham, NC,
USA) were grown in high glucose DMEM
supplemented with 10% FBS, 1% ampho-
tericin B solution and 1% penicillin/strepto-
mycin solution, at 37 °C with 5% CO2 and
95% relative humidity. Differentiation was
induced 48 h after cells reached full conflu-
ence with DMEM/F-12 medium supple-
mented with 10% FBS, 1% amphotericin B
solution, 1% penicillin/streptomycin solu-
tion, 0.5 μg/mL human insulin, 5 μM dex-
amethasone, 0.5 mM 3-isobutyl-1-methylx-
anthine (IBMX), 1 nM triiodothyronine (T3)
and 1 μM rosiglitazone. After 3 days, the
differentiation medium was switched to a
maintenance medium to which 0.5 μg/mL
human insulin and 1 nM T3 were added.
Maintenance medium was refreshed every 2
days. After the switch from differentiation
to maintenance medium, cells were treated
with 1, 3 and 5 μM BAIBA until analysis.
Cells were analyzed during differentiation
at day 4 (4d) and at day 8 (8d), at day 10
(10d); these time points correspond to 2, 6
and 8 days of BAIBA treatment, respective-
ly. A negative vehicle control (CTRL) was
established treating cells with sterile milliQ
water.
Cell viability assay
Cell viability was determined by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) assay. Medium was
removed from cells plated on a 96-well
plate and treated with different concentra-
tions of BAIBA. Prior to incubation with 5
mg/mL MTT solution in Hank’s balanced
salt solution (HBSS), cells were rinsed with
phosphate buffer saline (PBS) 1x.
Incubation with MTT solution was per-
formed at 37°C for 4 h. Accumulated for-
mazan was dissolved in dimethyl sulfoxide
(DMSO) and incubated overnight at 37°C.
The optical density was used as an indicator
of cell viability and was measured at 550
nm.
BODIPY staining
After cell fixation in a 2% formalin
solution diluted in PBS 1x at room temper-
ature (RT) for 15 min, the slides were
washed three times in PBS 1x and then
incubated in a solution of BODIPY493/503
in PBS 1x to fluorescently label lipid
droplets. The incubation was performed at
RT in dark for 45 min. After the incubation,
the slides were washed in PBS 1x three
times and then mounted with mounting
medium with DAPI. Images were acquired
with the fluorescence microscope Axio
Observer Z1 equipped with D-PLAN
Neofluar objective lenses with N.A. 0.75
and Infinity Color Corrected System (ICS)
and with AxioCam and Zen blue software
(Carl Zeiss, Jena, Germany). The filters
used for BODIPY were 470/525 nm, and
390/460 nm for DAPI.
Morphology of LDs
MRI_Lipid Droplets tool
(http://dev.mri.cnrs.fr/projects/imagej-
macros/wiki/Lipid Droplets_Tool), a macro
of ImageJ1.50b software (http://rsb.
info.nih.gov/ij/), was used to measure LD
area.19 The images were analyzed as already
described.20 For each LD area, perimeter,
maximum Feret diameter (MFD) and inte-
grated optical density (IOD) were meas-
ured. MFD is defined as the maximum dis-
tance between the two parallel planes
restricting the object perpendicular to that
direction and is a measure of an object size
along a specified direction. It is generally
used in optical microcopy to measure the
size of particles.21,22 The IOD reports the
average intensity/density of each object and
increases linearly with the triglycerides
content in 3T3-L1 adipocytes.23
Total area occupied by LDs in each
field at different days of differentiation was
calculated by summing up the area of each
LD. The count of cells in each field was
used to calculate the area and the number of
LDs per cell. The average area of a single
LD was calculated by dividing the area of
LDs/cells by the number of LDs/cells. The
area (μm2) and number of LDs were meas-
ured and counted on 15 fields for each time
point.
A nonparametric representation of the
LDs size probability density function (ker-
nel) was chosen to avoid making assump-
tions about the distribution of the data; the
kernel size distribution was evaluated with
a routine written in Matlab 7.1 (Mathworks,
MA, USA).
Of note, 2D examination of the LDs,
which are 3D objects, leads to an underesti-
mation of the size of bigger LDs with
respect to smaller LDs, increasing the prob-
ability to detect the first ones. Despite this
approach could affect the absolute kernel
density distribution of the LDs size, it is
used here in order to obtain a relative com-
parison only between different populations.
RNA extraction and RT-PCR
After culture medium removal from 6-
well plates, 1 mL/10 cm2 of TRIzol reagent
was added in each well and repeatedly
pipetted to induce a severe breakdown of
cell structures. These samples were imme-
diately processed with the PureLink™
RNA Mini Kit following the manufacturer’s
instructions.
The concentration of the extracted total
RNA was quantified using a spectropho-
tometer (NanoDrop 1000 Spectropho-tome-
ter; ThermoScientific, Wilmington, DE,
USA) and the purity of RNA samples
ranged between 1.8 and 1.9. RNA integrity
was evaluated through the observation of
18S and 28S ribosomal bands after elec-
trophoresis on 1% agarose gel, in the pres-
ence of GelRed. Primer3 Input software
was used to design primers.24 GenBank
accession, primer sequences, product
lengths and relative annealing temperatures
for each gene are listed in Table 1, accord-
ing to the HUGO Gene Nomenclature
Committee.
Total RNA (500 ng) from each sample
was reverse-transcribed and amplified using
an MJ thermal cycler (PT-100; MJ
Research, Inc., Waltham, MA, USA). For
each gene, an aliquot of cDNA samples
were pooled and standard curves with serial
dilution of pool were used to optimize PCR
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conditions and to calculate the efficiency,
fluorescence baseline and threshold.  Real
time PCRs were performed for each sample
in triplicate form using Platinum® SYBR®
Green qPCR SuperMix-UDG. cDNA con-
centrations and primers molarities were dif-
ferent for each gene and determined with
standard curves analyses. PCR amplifica-
tion was conduced applying 45 cycles (1
sec at 95ºC, 30 sec at the specific annealing
temperature, 30 sec at 72ºC) in a 96-well
spectrofluorometric thermal cycler (CFX,
Biorad, Milan Italy). The melting curve
analysis of amplification products was per-
formed at the end of each PCR reaction to
confirm that a single PCR product was
detected. 
The expression of target genes was nor-
malized using the TATA box-binding pro-
tein (Tbp) mRNA levels or geometric
means between Tbp and glyceraldehyde 3-
phosphate dehydrogenase (Gapdh) genes
and analyzed using DDCt method.25 For all
the cell culture experiments, the results are
generated from biological triplicates and
represent similar results from at least three
independent experiments.
Statistical analysis
Results are presented as relative values
(means ± SEM). All experiments were per-
formed at least three times. Two-way
ANOVA was used for statistical analysis for
MTT test by SPSS ver. 20.0 software. The
measurements of the area of LDs/cell, num-
ber of LDs/cell and the area of a single LD
were analyzed by SPSS ver. 20.0 software.
The results, obtained from ten biological
replicates, were compared using Kruskal-
Wallis statistical test followed by pairwise
comparisons using the Mann-Whitney
approach.
Results
Cell viability
The percentage of cell viability after
exposure of BAIBA at 4d, 8d and 10d was
always around 100% (data not shown). No
significant differences were observed for
time point and for concentration x time
point interaction. 
Lipid droplet distribution and
analysis
Figure 1 illustrated LDs formation in
3T3-L1 cells at 4d, 8d and 10d in presence
of different BAIBA doses. Interestingly, at
4d with 3 and 5 mM of BAIBA, cells
showed very small LDs (Figure 1, panels g
and l, respectively) in comparison to CTRL
cells (Figure 1a). 
Indeed, kernel densiy distribution sug-
gested an high number of cells with a small
Feret diameter when incubated with 5 mM
of BAIBA after 4 and 10 days of differenti-
ation (Figure 2a). The kernel distributions
of MFD at 4d, 8d and 10d are shown in
Figure 2a. For all the three time points, LD
size distribution of the treated cells is simi-
lar to that of control cells. In particular,
using the least squares method evaluated on
100 equally spaced Feret dimensions, the
differences at 4d between control and the
treatments (1 mM, 3 mM and 5 mM) are
respectively 0.0045, 0.0047 and 0.0538; at
8d are 0.0106, 0.0075 and 0.0062; at 10d
are 0.0367, 0.0807 and 0.0736. Figure 2b
evidenced statistically significant differ-
ences of IOD, number of LDs/cell and area
                                                                                                        Original Paper
[European Journal of Histochemistry 2018; 62:2984] [page 293]
Table 1. Oligonucleotide primer sequences for RT-PCR. 
Gene             GenBank accession                                    Primer sets                                              Product length (bp)               Tm (°C)
Tbp                              NM_013684.3                              Forward: 5’-CCAATGACTCCTATGACCCCTA-3’                                                104                                             58.5
                                                                                           Reverse: 5’-CAGCCAAGATTCACGGTAGAT-3’                                                      
Gapdh                         NM_008084                                 Forward: 5’-AATGTGTCCGTCGTGGATCTGA-3’
                                                                                           Reverse: 5’-AGTGTAGCCCAAGATGCCCTTC-3’                                               117                                              60
Ucp1                            NM_009463.3                              Forward: 5'-CTTTGCCTCACTCAGGATTGG-3’
                                                                                           Reverse: 5'-ACTGCCACACCTCCAGTCATT-3’                                                   123                                             59.8
Ppargc1a                    NM_008904.2                              Forward: 5'-TATGGAGTGACATAGAGTGTGCT-3’
                                                                                           Reverse: 5'-CTGGGCAAAGAGGCTGGTC-3’                                                     191                                             60.0
Cidea                           NM_007702.2                              Forward: 5-ATCACAACTGGCCTGGTTACG-3’
                                                                                           Reverse: 5’-TACTACCCGGTGTCCATTTCT-3’                                                   136                                             58.9
Cidec                           NM_178373.4                              Forward: 5’-ACCTTCGACCTGTACAAGCT-3’
                                                                                           Reverse: 5’-GTGCAGGTCATAGGAAAGCG-3’                                                    99                                              58.4
Elovl3                          NM_007703.2                              Forward: 5'-TTCTCACGCGGGTTAAAAATGG-3’
                                                                                           Reverse: 5'-GGCCAACAACGATGAGCAAC-3’                                                    139                                             58.9
Cyc1                             NM_025567.3                              Forward: 5’-GGCATCAGAACCAGAGCATG-3’
                                                                                           Reverse: 5’-CTGACCACTTATGCCGCTTC-3’                                                     110                                             59.4
Plin1                            NM_175640.2                              Forward: 5'-TGGACCACCTGGAGGAAAAG-3’
                                                                                           Reverse: 5'-CTTCGAAGGCGGGTAGAGATG-3’                                                 94                                              60.6
Prdm16                        NM_027504.3                              Forward: 5'-CCACCAGCGAGGACTTCAC-3’
                                                                                           Reverse: 5'-GGAGGACTCTCGTAGCTCGAA-3’                                                 107                                             61.4
Ppara                           NM_011144.6                              Forward: 5 -TCTGTCGGGATGTCACACAA-3
                                                                                           Reverse: 5 -CGGGCTTTGACCTTGTTCAT-3                                                     191                                             57.3
Bdnf                             NM_007540.4                              Forward: 5’-ATTACCTGGATGCCGCAAAC-3’
                                                                                           Reverse: 5’-CCTTCCTTGGTGTAACCCAT-3’                                                     241                                             58.5
Tbx1                             NM_011532.2                              Forward: 5’-AGGCGGAAGGAAGTGGTATT-3’
                                                                                           Reverse: 5’-TACCAGTATCTACACCGCCC-3’                                                     118                                             58.4
Tm, annealing temperature; Tbp; TATA box binding protein; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Ucp1, uncoupling protein 1; Ppargc1a, peroxisome proliferator-activated receptor  coac-
tivator 1 α; Cidea, cell death-inducing DFFA-like effector A; Cidec, cell death inducing DFFA like effector C; Elovl3, elongation of very long chain fatty acids protein 3; Cyc1, cytochrome C1; Plin1, perilipin
1; Prdm16, proline rich domain containing 16; Ppara, peroxisome proliferator-activated receptor α; Bdnf, brain derived neurotrophic factor; Tbx1, T-box 1.
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of a single LD/cell at 4d in presence of dif-
ferent BAIBA doses. To avoid any technical
or biological variance due to cell number
among slides, the total LD area was normal-
ized to the number of cells.
The IOD significantly (P<0.05)
decreased between 3 mM and 5 mM, the
number of LDs/cell increased between
CTRL and 1 mM (P<0.05) and between
CTRL and 5 mM (P<0.01). The area of a
single LD/cell was significantly different
between CTRL and 5 mM (P<0.001). Figure
2b evidenced statistically significant differ-
ences in the area of LDs at 10d. In particu-
lar, the area was higher (P<0.05) in CTRL
and 3 mM in comparison to 5 mM. No statis-
tical differences were found at 8d. 
The decrease in IOD, which is inversely
related with the amount of triglycerides in
LDs, the lowest area of a single LD and the
increase of the number of LDs/cell
observed with 5 mM BAIBA at 4d can
account for a LD generation through the
lipolytic release of fatty acids.
Transcription data analysis
Figure 3 indicated the relationship
between the different concentrations of
BAIBA and the significant differentially
expressed genes at 4d and 8d, respectively.
At 10d, gene expression did not display any
significant variation. Only significant differ-
entially expressed genes were showed. At 4d
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Figure 1. Lipid droplet pattern (stained with BODIPY 493/503) in fixed 3T3-L1 cells at 4d (a,d,g,l), 8d (b,e,h,m), and 10d (c,f,i,n).
Control cells (a,b,c) and cells treated with 1 mM (d,e,f ), 3 mM (g,h,i) and 5 mM (l,m,n) of BAIBA are shown. Nuclear staining DAPI.
Images are representative of n. 5 biological replicates. Scale bars:  20 mm.
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Figure 2 a) Kernel distribution of the Feret of the lipid droplets at 4, 8 and 10 days of differentiation in control and BAIBA-treated
cells. b) Lipid droplet measurements on 3T3-L1 in presence of different BAIBA doses: Integrated optical density (IOD), number of
LDs per cell, area of single LD after 4 days of differentiation and total area of LD and after 10 days of differentiation. Box plots show
median (horizontal lines), first-to-third quartile (box), and the extreme values with the interquartile range (vertical lines). The area
measures are expressed in mm2 and are the average of 10 fields of each concentration. ***P<0.001, **P<0.05.
Figure 3. Differentially expressed genes between BAIBA doses
after 4 and 8 days of differentiation. a) Genes involved in brown-
ing (three biological replicates) at 4d. Tbx1, T-box 1; Ppargc1a,
peroxisome proliferator-activated receptor γ coactivator 1 α;
Ppara, peroxisome proliferator-activated receptor α; Prdm16,
proline rich domain containing 16; Bdnf, brain derived neu-
rotrophic factor. b) Lipid droplets related genes at 4d. Cidea, cell
death-inducing DFFA-like effector A; Plin1, perilipin 1. c) Genes
involved in browning (three biological replicates) at 8d. Ucp1,
uncoupling protein 1. Bars represent the mean plus/minus stan-
dard error of the mean (SEM). *P<0.05; **P<0.01; ***P<0.001.
[European Journal of Histochemistry 2018; 62:2984] [page 295]
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the expression of Tbx1 was significantly
(P<0.05) different between 5 mM and lower
doses. No significant differences were found
with CTRL, maybe due to the high variabili-
ty at the 5 mM dose. Ppargc1a (P<0.05)
Prdm16, and Bdnf were up-regulated
(P<0.002) at the same dose, while Ppara dis-
played significant differences for 1 mM and 5
mM in comparison to CTRL and 3 mM
(Figure 3a). Cidea was significantly upregu-
lated (P<0.05) at 5 mM, whereas Plin1
showed the significantly (P<0.05) lowest
expression at 5 mM in comparison to CTRL
(Figure 3b).The expression of Ppargc1a,
Ucp1 and Ppara (P<0.001) was at its highest
with 1 and 3 mM BAIBA doses in compari-
son to CTRL and 5 mM (Figure 3c).
Discussion
The present study reports the browning
effect of BAIBA at different concentrations
on 3T3-L1 cells at 4, 8 and 10 days of dif-
ferentiation. It provides evidence showing
the dynamics of LD morphology together
with the expression of a panel of genes
related to adaptive thermogenesis and LD
formation. Although it is well established
that this molecule, secreted by myocytes
during exercise and circulating in blood,
triggers the browning of WAT, no studies
were conducted after its description by
Roberts et al. in 2014.15 This study tested
for the first time on 3T3-L1 cells known as
reliable cellular model used in obesity
researches, the browning effect of BAIBA
by measuring variations in morphology of
LDs that have recently attracted great inter-
est as dynamic structures at the hub of lipid
and energy metabolism. 
It is largely known that brown
adipocytes are occupied by multilocular
LDs to facilitate the efficiency of lipases
and subsequent uncoupling in response to
cold or other stimuli.26 Recently, changes in
LD dimension and in their associated pro-
teins, such as CIDEC, CIDEA and PLIN1,
have been demonstrated after the stimula-
tion of browning.6 In the present study, sta-
tistical analysis evidenced that at 4 days of
differentiation and at the highest BAIBA
concentration, the number of LDs per cell
increased in comparison to control cells,
whereas the surface area of a single LD sig-
nificantly decreased. The decrease of IOD
observed at the same time and concentra-
tion suggested a smaller triglyceride accu-
mulation compared to controls.
Interestingly these results occurred at 4
days of differentiation, that correspond to
the peak of lipogenesis.27 The results on LD
morphology at 4d were corroborated by
gene expression analysis. The browning
adaptation included the up-regulation of
Ppargc1a, Tbx1, Ucp1, Cidea, Elovl3 and
Prdm16. In particular, 5 mM BAIBA at 4d
influenced the expression of Tbx1 (Figure
3a), while the expression of Ucp1 was
induced after 8 days of differentiation
(Figure 3c). This is in agreement with the
results obtained on human primary subcuta-
neous adipocytes treated with irisin, a
myokine with dubious potential role in
inducing browning of white adipose tis-
sue.28,29 Moreover, a significant increase of
Cidea with 5 mM BAIBA treatment (Figure
3b), but not of Cidec, was observed, as
reported in cells obtained by primary stro-
mal vascular fraction of inguinal WAT of
mice.15 Cidea is known as a brown
adipocyte specific gene, related to multiloc-
ular phenotype,8 and it is induced in WAT
following cold exposure or β-adrenergic
signaling.6,30 In fact, the highest surface/vol-
ume ratio of smaller LDs increases the con-
tact area of the LD with lipases and the sub-
sequent facilitation of free fatty acids trans-
port to mitochondria. CIDEA and CIDEC
proteins are involved together in the fusion
and enlargement of LDs, but while CIDEC
is crucial in the formation of large LD in
WAT, CIDEA alone is not sufficient.27
Recently, Nishimoto et al demonstrated
that, in BAT, an isoform of CIDEC inhibits
the homo dimerization of CIDEA and sup-
presses the formation of large LDs.31 As fur-
ther evidence of browning effect induced by
BAIBA at 4d, Plin1 gene was significantly
down-regulated by all treatments in com-
parison to control (Figure 3b). In fact, per-
ilipin 1 cooperates with CIDEC, but not
with CIDEA, in inducing a super-sized,
unilocular LD.32
After 4 days of differentiation, the
expression of Ppargc1a and Prdm16 was
also significantly increased by 5 mM
BAIBA. This is in line with in vivo experi-
ments that showed that exercise training has
marked effects on mitochondrial gene
expression and activity in subcutaneous
WAT in mice and human.33 Ppargc1a con-
trols mitochondrial biogenesis and heat pro-
duction through induction of expression of
Ucp1 and other respiratory factors.34 The
higher expression level of this gene and
Prdm16, a classic marker of brown fat, at 4d
and later at 8d is coherent with the followed
higher transcription of Ucp1 (Figure 3c).
PPARα, a nuclear receptor, stimulates
genes involved in mitochondrial fatty acid
oxidation and increases the expression of
Ucp1 by directly interacting with Ppargc1a
in primary murine brown adipocytes.35
Roberts et al. demonstrated that browning
process induced by BAIBA involved a spe-
cific Ppara-dependent mechanism,15 with-
out clarifying the upstream mechanism of
action. Very recently, it has been shown that
the loss of Ppara affected mature brown
adipocytes by reducing the expression of
brown markers in vitro but not in vivo, sug-
gesting as well an important role of glycerol
kinase in maintaining the activity of PPAR
proteins.36 Moreover, it should be consid-
ered that PPARα regulates Cidea in mouse
liver without altering the expression of
Ucp1.37 In the present paper, the expression
of Ppara is induced by 5 mM BAIBA at 4d
and its expression was further increased at
8d with the lowest BAIBA concentration, as
well as the expression of Ppargc1a and
Ucp1 (Figure 3c). However, at 8d no signif-
icant variations in LD morphology and
number were appreciated, as observed in
PPARγ2-programmed cells treated with
BAIBA.15 At 10d, BAIBA treatments did
not significantly affect gene expression,
although a decrease in the area of LDs was
detected at the highest dose (Figure 3d).
BDNF is a neurotrophin expressed in
brain, which regulates neuronal develop-
ment and plasticity. However, it was also
found in non-neuronal tissues, such as WAT
and BAT in rodents and cows,38,39 where it
could be involved in fat metabolism and in
the activation of the sympathetic
response.39,40 Moreover, mRNA and protein
BDNF expression increases in human
skeletal muscle after exercise, suggesting a
role, as a myokine, on skeletal muscle
metabolism,41 by enhancing local and
peripheral fatty acid oxidation.42 The action
of BAIBA at 4d on 3T3-L1 cells increased
the Bdnf expression (Figure 3a), which in
turn activates AMPK,43 thus facilitating the
browning conversion.
This paper demonstrated that BAIBA
promotes browning phenotype on 3T3-L1
cells during first 4-8 days of differentiation.
In agreement with Roberts et al.15 the high-
est concentration during the early days of
differentiation produced the strongest effect
on cells in terms of LD dynamics and
expression of beiging gene markers. After 8
days of differentiation, no changes were
identified on LD morphology, although a
browning effect was achieved as observed
by brown gene marker expression. This
browning effect appeared to be lost in cells
after 10 days of differentiation. 
The action of BAIBA significantly
affects the early stage of adipocyte differen-
tiation and can reflect a rapid adaptation of
adipose tissue to physical exercise. This
connection stresses the beneficial impact of
physical exercise on metabolic health, pro-
viding more evidence of the preventive and
therapeutic role of physical activity against
obesity.
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